当前位置：首页 > 文献互助 > 互助详情

期刊论文1482O A phase III study comparing methotrexate (M), adriamycin (A) and cisplatin (P) with MAP + ifosfamide (MAP + IF) for the treatment of osteosarcoma: JCOG0905复制

用户VGsBg1MqXziw 8天前 36 已完结

1. 系统已在2025-11-30 22:02:17对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.annonc.2022.07.1585复制

文献链接: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02463804/full复制

其他信息:

上一篇：Molecular basis of RNA-dependent RNA polymerase II activity

下一篇：443TiP A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents, and young adults with relapsed ...

互助时间线

2025-11-28 15:09:17 [完结求助]

系统完结了求助, 已自动确认了书籍收藏家应助的文件是正确的, 求助状态变成已完结

2025-11-23 22:02:17 [上传文件]

书籍收藏家上传了文件(pdf 162.45 KB), 求助状态变成待确认

2025-11-23 15:09:17 [发起求助]

最新发布的求助

{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 40分钟前

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 1小时前

Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive … 1小时前

术后恶心呕吐诊疗指南（2025版） 2小时前

Organic A-cationsin metal halide perovskitephotovoltaics 2小时前

Optimizing SiN Composition for Enhanced Charge-Trapping in Next-Generation 3D NAND Flash Memories 2小时前

Increasing the dimensionality of transistors with hydrogels 3小时前

In vivo CAR T cell generation to treat cancer and autoimmune disease 3小时前

Targeting DNA Damage Repair Pathways Beyond PARP Inhibition 3小时前

Home Overview Highlights News Mentions Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial 3小时前

Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial 3小时前

https://onlinelibrary.wiley.com/doi/epdf/10.1002/anie.202521847 3小时前